Results 151 to 160 of about 58,536 (309)

Polymorphism of pea storage protein convicilin

open access: yesВестник Орловского государственного аграрного университета, 2014
Pea convicilin could hinder physico-chemical properties of protein isolates. Pea accessions without convicilin or with its unusual isoforms could be used in pea breeding on high quality of storage proteins. Polymorphism of convicilin was studied with use of 60 accessions of genus Pisum L.
Selikhova, T., Bobkov, S.
openaire   +2 more sources

The relationship between the cannabinoids and cardiac remodelling: A comprehensive review of pivotal mechanisms and emerging evidence

open access: yesBritish Journal of Pharmacology, EarlyView.
Cardiac remodelling and fibrosis after myocardial infarction or during chronic diseases, such as arterial and pulmonary hypertension or diabetes mellitus, continue to be the more important prognostic factors in determining survival, and so the search for effective anti‐fibrotic interventions is an important target for research and therapy in cardiology.
Anna Krzyżewska   +2 more
wiley   +1 more source

Effects of deamidation by protein glutaminase on the flavor binding properties of pea protein isolate. [PDF]

open access: yesFood Chem X
Siripitakpong P   +3 more
europepmc   +1 more source

Cannabidiol and cannabigerol ameliorate steatotic liver disease via phosphocreatine buffering and lysosomal restoration

open access: yesBritish Journal of Pharmacology, EarlyView.
Cannabidiol (CBD) and cannabigerol (CBG) alleviate hepatic steatosis in obese mice by shifting energy buffering towards phosphocreatine and enhancing lysosomal lipid degradation and trafficking. These effects are associated with increased creatine kinase activity and lysobisphosphatidic acid (LBPA) levels, highlighting a previously unrecognised ...
Radka Kočvarová   +12 more
wiley   +1 more source

Analysis of Peripheral T Cell Profiling and Plasma Proteomics in Advanced NSCLC Patients Treated With Atezolizumab

open access: yesCancer Science, EarlyView.
This study found immune markers that may predict how well patients with advanced lung cancer respond to atezolizumab. Higher levels of certain T cells were linked to better survival. Specific patterns suggested a worse prognosis for some patients. ABSTRACT We investigated immunologic biomarkers that predict outcomes of patients with previously treated ...
Atsuto Mouri   +24 more
wiley   +1 more source

Home - About - Disclaimer - Privacy